Stay updated on DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Sign up to get notified when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.

Latest updates to the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page
- Check2 days agoChange DetectedAdds a related topics section featuring Type 2 diabetes and a MedlinePlus Genetics link, enhancing navigation to background information for readers.SummaryDifference0.1%

- Check9 days agoChange DetectedThe study details no longer display the condition 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics', altering how the study is categorized and what related topics appear.SummaryDifference0.1%

- Check17 days agoChange DetectedType 2 diabetes is added as a listed condition and related topics include MedlinePlus Genetics. The page revision version has been updated from v3.5.3 to v3.5.4.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page no longer lists Type 2 diabetes as the study condition. It also removes the related topics subsection, including the MedlinePlus Genetics link.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, indicating a minor update to the page version. This change does not modify any content or data on the page.SummaryDifference0.0%

- Check45 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Enter your email address, and we'll notify you when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.